during the quickly evolving area of cancer therapeutics, comprehending the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is crucial for developing successful therapies. Just about the most promising ways is using in vitro bystander impact assays, which play a pivotal job in enhancing therapeutic efficacy. These assays, furnished by provid